Byakangelicol
Product Specifications
CAS Number
26091-79-2
Target
COX
Related Pathways
Neuroscience|||Immunology/Inflammation
Purity
0.9955
Bioactivity
1. Byakangelicol may inhibit P-gp expressed at the BBB even under in vivo conditions. 2. Byakangelicol can inhibit IL-1beta-induced PGE2 release in A549 cells; this inhibition may be mediated by suppression of COX-2 expression and the activity of COX-2 enzyme, thus it may have therapeutic potential as an anti-inflammatory drug on airway inflammation.
Smiles
[H][C@]1(COc2c3occc3c(OC)c3ccc(=O)oc23)OC1(C)C
Molecular Formula
C17H16O6
Molecular Weight
316.31
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
M2363-10C-APC 100 µL
MAP Kinase Kinase 3 (Dual Specificity Mitogen-activated Protein Kinase Kinase 3, Mitogen-activated Protein Kinase Kinase 3, MAP2K3, MAPKK 3, MKK3, MAPK/ERK Kinase 3, MEK 3, MEK3, PRKMK3, Stress-activated Protein Kinase Kinase 2, SAPK Kinase 2, SAPKK2, SAPKK-2, SKK2) (APC) discontinued
Ask
View Details 
